Portfolio Company Job Board

Find a job at one of our innovative portfolio companies
Sands Capital
84
companies
5,504
Jobs

Locations

St. Louis, MO, USA

industry

Biotechnology · DeepTech · Health

Size

51-200 employees

Stage

Series B

founded in

2018

Wugen is a clinical-stage biotechnology company developing allogeneic, off-the-shelf cellular therapies for cancer, specifically targeting solid tumors, acute myeloid leukemia (AML), and T-cell malignancies. Their innovative NK cell and CAR-T immuno-oncology therapies are derived from healthy donors and are engineered to enhance their efficacy in eliminating cancer cells. With a strong pipeline supported by issued and pending patents, Wugen is positioned to address significant unmet needs in cancer treatment, aiming to provide convenient, effective therapies for patients.

Something looks off?
Open jobs at Wugen

On-site & Remote